Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat
- PMID: 10193764
- PMCID: PMC1571228
- DOI: 10.1038/sj.bjp.0702348
Effects of the prostanoid EP3-receptor agonists M&B 28767 and GR 63799X on infarct size caused by regional myocardial ischaemia in the anaesthetized rat
Abstract
1. This study investigates the effects of two agonists of the prostanoid EP3-receptor (M&B 28767 and GR 63799X) on the infarct size caused by regional myocardial ischaemia and reperfusion in the anaesthetized rat. 2. One hundred and sixty-seven, male Wistar rats were anaesthetized (thiopentone, 120 mg kg(-1) i.p.), ventilated (8-10 ml kg(-1), 70 strokes min(-1), inspiratory oxygen concentration: 30%; PEEP: 1-2 mmHg) and subjected to occlusion of the left anterior descending coronary artery (LAD, for 7.5, 15, 25, 35, 45 or 60 min) followed by reperfusion (2 h). Infarct size was determined by staining of viable myocardium with a tetrazolium stain (NBT), histological evaluation by light and electron microscopy and determination of the plasma levels of cardiac troponin T. 3. M&B 28767 (0.5 microg kg(-1) min(-1), i.v., n=7) or GR 63799X (3 microg kg(-1) min(-1), i.v., n=7) caused significant reductions in infarct size from 60+/-3% (25 min ischaemia and 2 h reperfusion; saline-control, n=8) to 39+/-6 and 38+/-4% of the area at risk, without causing a significant fall in blood pressure. Pretreatment of rats with 5-hydroxydecanoate (5-HD), an inhibitor of ATP-sensitive potassium channels, attenuated the cardioprotective effects of both EP3-receptor agonists. The reduction in infarct size afforded by M&B 28767 was also abolished by glibenclamide and the protein kinase C (PKC) inhibitors staurosporine and chelerythrine. 4. Thus, M&B 28767 and GR 63799X reduce myocardial infarct size in the rat by a mechanism(s) which involves the activation of PKC and the opening of ATP-sensitive potassium channels.
Figures






Similar articles
-
Reduction of myocardial injury by the EP3 receptor agonist TEI-3356. Role of protein kinase C and of K(ATP)-channels.Eur J Pharmacol. 1999 Feb 12;367(1):33-9. doi: 10.1016/s0014-2999(98)00963-7. Eur J Pharmacol. 1999. PMID: 10082262
-
Reduction by prostaglandin E1 or prostaglandin E0 of myocardial infarct size in the rabbit by activation of ATP-sensitive potassium channels.Br J Pharmacol. 1995 Nov;116(5):2435-40. doi: 10.1111/j.1476-5381.1995.tb15092.x. Br J Pharmacol. 1995. PMID: 8581281 Free PMC article.
-
Reduction of myocardial infarct size with sCR1sLe(x), an alternatively glycosylated form of human soluble complement receptor type 1 (sCR1), possessing sialyl Lewis x.Br J Pharmacol. 1999 Nov;128(5):945-52. doi: 10.1038/sj.bjp.0702889. Br J Pharmacol. 1999. PMID: 10556930 Free PMC article.
-
Selective activation of the prostanoid EP(3) receptor reduces myocardial infarct size in rodents.Arterioscler Thromb Vasc Biol. 1999 Sep;19(9):2141-7. doi: 10.1161/01.atv.19.9.2141. Arterioscler Thromb Vasc Biol. 1999. PMID: 10479656
-
Selective activation of E-type prostanoid(3)-receptors reduces myocardial infarct size. A novel insight into the cardioprotective effects of prostaglandins.Pharmacol Ther. 2000 Jul;87(1):61-7. doi: 10.1016/s0163-7258(00)00069-3. Pharmacol Ther. 2000. PMID: 10924742 Review.
Cited by
-
Inhibition of c-Jun N-terminal kinase decreases cardiomyocyte apoptosis and infarct size after myocardial ischemia and reperfusion in anaesthetized rats.Br J Pharmacol. 2004 Jul;142(6):953-60. doi: 10.1038/sj.bjp.0705873. Epub 2004 Jun 21. Br J Pharmacol. 2004. PMID: 15210584 Free PMC article.
-
Activation of E-prostanoid 3 receptor in macrophages facilitates cardiac healing after myocardial infarction.Nat Commun. 2017 Mar 3;8:14656. doi: 10.1038/ncomms14656. Nat Commun. 2017. PMID: 28256515 Free PMC article.
-
The cardioprotective effect of microemulsion propofol against ischemia and reperfusion injury in isolated rat heart.Korean J Anesthesiol. 2012 Apr;62(4):358-64. doi: 10.4097/kjae.2012.62.4.358. Epub 2012 Apr 23. Korean J Anesthesiol. 2012. PMID: 22558503 Free PMC article.
-
Magnesium Lithospermate B Protects Cardiomyocytes from Ischemic Injury Via Inhibition of TAB1-p38 Apoptosis Signaling.Front Pharmacol. 2010 Aug 24;1:111. doi: 10.3389/fphar.2010.00111. eCollection 2010. Front Pharmacol. 2010. PMID: 21607062 Free PMC article.
-
Prostanoid receptor antagonists: development strategies and therapeutic applications.Br J Pharmacol. 2009 Sep;158(1):104-45. doi: 10.1111/j.1476-5381.2009.00317.x. Epub 2009 Jul 15. Br J Pharmacol. 2009. PMID: 19624532 Free PMC article. Review.
References
-
- ADAMS J.E., ABENDSCHEIN D.R., JAFFE A.S. Biochemical markers of myocardial injury: is MB creatine kinase the choice for 1990s. Circ. 1993;88:750–763. - PubMed
-
- BALLER D., BRETSCHNEIDER H.J., HELLIGE G. A critical look at currently used indices of myocardial oxygen consumption. Basic Res. Cardiol. 1981;76:163–181. - PubMed
-
- BANCROFT J.D., STEVENS A. Theory and Practice of Histological Techniques 1995Edinburgh: Churchill Livingstone; ed. Bancroft, J.D. & Stevens, A
-
- BAROLDI G. Different types of myocardial necrosis in coronary heart disease: A pathophysiological review of their functional significance. Am. Heart. J. 1975;89:742–752. - PubMed
-
- COLEMAN R.A., KENNEDY I., HUMPHREY P.P.A., BUNCE K., LUMLEY P. Comprehensive Medicinal Chemistry 1990Oxford: Pergamon Press; 643ed. Hansch, C., Samnes, P.G., Taylor, J.B. & Emmett, J.C. p
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous